New Forecasts: Here's What Analysts Think The Future Holds For Scales Corporation Limited (NZSE:SCL)

Celebrations may be in order for Scales Corporation Limited (NZSE:SCL) shareholders, with the analysts delivering a significant upgrade to their statutory estimates for the company. The analysts have sharply increased their revenue numbers, with a view that Scales will make substantially more sales than they'd previously expected. The stock price has risen 4.3% to NZ$7.10 over the past week, suggesting investors are becoming more optimistic. Could this big upgrade push the stock even higher?

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

After this upgrade, Scales' two analysts are now forecasting revenues of NZ$1.4b in 2026. This would be a substantial 58% improvement in sales compared to the last 12 months. Before the latest update, the analysts were foreseeing NZ$1.3b of revenue in 2026. The consensus has definitely become more optimistic, showing a nice increase in revenue forecasts.

Check out our latest analysis for Scales

The consensus price target rose 10% to NZ$7.68, with the analysts clearly more optimistic about Scales' prospects following this update.

These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the Scales' past performance and to peers in the same industry. It's clear from the latest estimates that Scales' rate of growth is expected to accelerate meaningfully, with the forecast 58% annualised revenue growth to the end of 2026 noticeably faster than its historical growth of 8.4% p.a. over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to grow their revenue at 7.5% per year. Factoring in the forecast acceleration in revenue, it's pretty clear that Scales is expected to grow much faster than its industry.

The Bottom Line

The highlight for us was that analysts increased their revenue forecasts for Scales this year. The analysts also expect revenues to grow faster than the wider market. There was also a nice increase in the price target, with analysts apparently feeling that the intrinsic value of the business is improving. Given that analysts appear to be expecting substantial improvement in the sales pipeline, now could be the right time to take another look at Scales.

Looking to learn more? At least one of Scales' two analysts has provided estimates out to 2028, which can be seen for free on our platform here.

Another way to search for interesting companies that could be reaching an inflection point is to track whether management are buying or selling, with our free list of growing companies backed by insiders.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.